CMS certification 050239
Glendale Adventist Medical Center
1509 E Wilson Terrace, Glendale, CA 91206
Glendale Adventist Medical Center has a CMS overall rating of 4 out of 5 stars. 69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 6 and worse on 3. Emergency patients spend a median of 3 h 3 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 759 completed surveys, 15% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | CA | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 385 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 3 min | 2 h 54 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 22 visits sampled | 6 h 30 min | 4 h 20 min | 4 h 17 min |
| Left before being seen Lower is better · 62,665 patients | 1% | 2% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 126 patients | 90% | 70% | 65% |
How Glendale Adventist Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Glendale Adventist Medical CenterThis hospital | 4/5 | 69% | 3 h 3 min | 6 better 3 worse |
| Glendale Mem Hospital & Hlth CenterSame city | 4/5 | 67% | 3 h 16 min | 3 better 1 worse |
| USC Verdugo Hills HospitalSame city | 4/5 | 65% | 4 h 3 min | 4 better 2 worse |
| Huntington HospitalSame county · Pasadena | Not rated | 76% | 4 h 28 min | 3 better 2 worse |
| UCLA West Valley Medical CenterSame county · West Hills | 2/5 | 53% | 2 h 52 min | 1 better 3 worse |
| Northridge Hospital Medical CenterSame county · Northridge | 4/5 | 66% | 3 h 35 min | 4 better 2 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Glendale.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 3,776 cases | Too few cases | 3.3% | 3.9% |
| Heart attack 312 cases | Too few cases | 11% | 11.9% |
| Heart failure 787 cases | Too few cases | 6.7% | 11.1% |
| Pneumonia 1,340 cases | Too few cases | 11.9% | 15.2% |
| Stroke 352 cases | Too few cases | 9.3% | 11.9% |
| COPD 142 cases | Too few cases | 7% | 8.6% |
| Heart bypass surgery (CABG) 70 cases | Too few cases | 2.1% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.75 likely 0.48 – 1.01 | 1 |
| After hip or knee replacement 112 cases | Too few cases | 4.7% | 4.1% |
| Deaths after a serious but treatable surgical complication 188 cases | No different | 161.81 per 1,000 likely 119.07 per 1,000 – 204.55 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 9,330 cases | Better | 0.08 per 1,000 likely 0 per 1,000 – 0.57 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 11,108 cases | No different | 0.13 per 1,000 likely 0 per 1,000 – 0.31 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 11,736 cases | No different | 0.18 per 1,000 likely 0 per 1,000 – 0.35 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 2,540 cases | No different | 1.38 per 1,000 likely 0.04 per 1,000 – 2.71 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 882 cases | No different | 1.76 per 1,000 likely 0.19 per 1,000 – 3.33 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 947 cases | No different | 8.3 per 1,000 likely 2.34 per 1,000 – 14.26 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 2,564 cases | No different | 3 per 1,000 likely 1.22 per 1,000 – 4.78 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 895 cases | No different | 5.26 per 1,000 likely 1.99 per 1,000 – 8.53 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 431 cases | No different | 1.94 per 1,000 likely 0.47 per 1,000 – 3.41 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,817 cases | No different | 0.9 per 1,000 likely 0.01 per 1,000 – 1.79 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.28 likely 0.05 – 0.92 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.07 likely 0 – 0.36 | 1 |
| Surgical site infections after colon surgery | No different | 0.23 likely 0.01 – 1.15 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.98 likely 0.05 – 4.82 | 1 |
| MRSA bloodstream infections | No different | 0.69 likely 0.22 – 1.66 | 1 |
| C. diff intestinal infections | Better | 0.09 likely 0.03 – 0.19 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 368 cases | Too few cases | 15.7% | 14.4% |
| Readmitted after heart failure 930 cases | Too few cases | 19.2% | 21.3% |
| Readmitted after pneumonia 1,397 cases | Too few cases | 18.9% | 17.3% |
| Readmitted after COPD 171 cases | Too few cases | 19.9% | 20% |
| Readmitted after heart bypass surgery 68 cases | Too few cases | 9.4% | 11% |
| Readmitted after hip or knee replacement 105 cases | Too few cases | 6.9% | 5.8% |
| Days back in hospital after a heart attack 370 cases | Too few cases | 30.6 days per 100 | — |
| Days back in hospital after heart failure 1,036 cases | Too few cases | -4.5 days per 100 | — |
| Days back in hospital after pneumonia 1,549 cases | Too few cases | 30.9 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 183 cases | No different | 13.2 per 1,000 likely 9.8 per 1,000 – 17.5 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 25 cases | No different | 10.9 per 100 likely 7.5 per 100 – 15.5 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 25 cases | No different | 5.3 per 100 likely 3.3 per 100 – 8.5 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 416 cases | No different | 1.1 likely 0.8 – 1.4 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
162 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 27 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Pharmacist | 32 |
| Psychiatric/Mental Health | 16 |
| Anesthesiology | 14 |
| Family Medicine | 11 |
| Emergency Medicine | 10 |
| Diagnostic Radiology | 8 |
| Acute Care | 7 |
| Psychiatric/Mental Health, Adult | 6 |
| Family | 5 |
| Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist | 5 |
| Registered Nurse | 4 |
| Dietitian, Registered | 3 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $314,573
- 2020 $1.3M
- 2021 $888,153
- 2022 $454,723
- 2023 $567,314
- 2024 $832,636
- 2025 $420,939
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $21,364 | 3 |
| Space rental and facility fees | $2,500 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Novartis Pharmaceuticals Corporation | $163,711 | 2 |
| Janssen Research & Development, LLC | $157,092 | 22 |
| Caris MPI, Inc. | $26,000 | 1 |
| AngioDynamics, Inc. | $18,667 | 2 |
| AstraZeneca Pharmaceuticals LP | $16,500 | 1 |
| Pfizer INC. | $14,274 | 3 |
| Ucb Sa | $11,043 | 7 |
| Stemline Therapeutics Inc. | $8,456 | 27 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participant… Novartis Pharmaceuticals Corporation | $163,711 |
| A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) Janssen Research & Development, LLC | $112,892 |
| A Phase 2b, Open-Label, Two-cohort Study of Subcutaneous Amivantamab in Combination with Lazertinib as First-Line Treatment, or Subcutaneous Amivanta… Janssen Research & Development, LLC | $44,200 |
| DISCOVERING NOVEL CANCER TREATMENT OPTIONS USING A COMPREHENSIVE NGS-BASED MOLECULAR TESTING PANEL IN THE COMMUNITY SETTING (DINOSAUR) Caris MPI, Inc. | $26,000 |
| a randomised,open label,phase III study of saruparib AZD5305 plus camizestrant compared with physicians choice CDK4 6 inhibitor plus endocrine therap… AstraZeneca Pharmaceuticals LP | $16,500 |
| TALAPRO3 A PHASE 3 RANDOMIZED DOUBLEBLIND STUDY OF TALAZOPARIB WITH ENZALUTAMIDE VERSUS PLACEBO WITH ENZALUTAMIDE IN MEN WITH DDR GENE MUTATED METAST… PFIZER INC. | $13,274 |
| EMERALD: Phase 3 Trial of Elacestrant vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer (EMERALD) Stemline Therapeutics Inc. | $8,456 |
| A single-center, placebo-controlled, participant-blind, investigator-blind, randomized, multiple ascending dose in titration study to assess the safe… UCB SA · NCT06970301 | $7,921 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Glendale Adventist Medical Center
Is Glendale Adventist Medical Center a good hospital?
Glendale Adventist Medical Center has a CMS overall rating of 4 out of 5 stars. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 6 and worse on 3. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Glendale Adventist Medical Center?
69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 759 completed HCAHPS surveys.
How long is the wait in the Glendale Adventist Medical Center emergency room?
Emergency patients spend a median of 3 h 3 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 1% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Glendale Adventist Medical Center receive money from drug and device companies?
Drug and device makers reported $420,939 in payments to Glendale Adventist Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.